MedPath

Zyprexa

These highlights do not include all the information needed to use ZYPREXA safely and effectively. See full prescribing information for ZYPREXA. ZYPREXA (olanzapine) Tablet for Oral use ZYPREXA ZYDIS (olanzapine) Tablet, Orally Disintegrating for Oral use ZYPREXA IntraMuscular (olanzapine) Injection, Powder, For Solution for Intramuscular use Initial U.S. Approval: 1996

Approved
Approval ID

a3c9ea17-3793-494a-8b32-44e48f9f4503

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 1, 2010

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 3

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Olanzapine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-142
Application NumberNDA020592
Product Classification
M
Marketing Category
C73594
G
Generic Name
Olanzapine
Product Specifications
Route of AdministrationORAL
Effective DateDecember 4, 2009
FDA Product Classification

INGREDIENTS (11)

OlanzapineActive
Quantity: 10 mg in 1 1
Code: N7U69T4SZR
Classification: ACTIB
Carnauba waxInactive
Code: R12CBM0EIZ
Classification: IACT
CrospovidoneInactive
Code: 68401960MK
Classification: IACT
Magnesium stearateInactive
Code: 70097M6I30
Classification: IACT
Hydroxypropyl celluloseInactive
Code: RFW2ET671P
Classification: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
LactoseInactive
Code: J2B2A4N98G
Classification: IACT
Titanium dioxideInactive
Code: 15FIX9V2JP
Classification: IACT
Cellulose, MicrocrystallineInactive
Code: OP1R32D61U
Classification: IACT
POLYETHYLENE GLYCOLInactive
Code: 3WJQ0SDW1A
Classification: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8H
Classification: IACT

Olanzapine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-140
Application NumberNDA020592
Product Classification
M
Marketing Category
C73594
G
Generic Name
Olanzapine
Product Specifications
Route of AdministrationORAL
Effective DateDecember 4, 2009
FDA Product Classification

INGREDIENTS (11)

OlanzapineActive
Quantity: 5 mg in 1 1
Code: N7U69T4SZR
Classification: ACTIB
Carnauba waxInactive
Code: R12CBM0EIZ
Classification: IACT
Magnesium stearateInactive
Code: 70097M6I30
Classification: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
Hydroxypropyl celluloseInactive
Code: RFW2ET671P
Classification: IACT
LactoseInactive
Code: J2B2A4N98G
Classification: IACT
Cellulose, MicrocrystallineInactive
Code: OP1R32D61U
Classification: IACT
Titanium dioxideInactive
Code: 15FIX9V2JP
Classification: IACT
POLYETHYLENE GLYCOLInactive
Code: 3WJQ0SDW1A
Classification: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8H
Classification: IACT
CrospovidoneInactive
Code: 68401960MK
Classification: IACT

Olanzapine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-144
Application NumberNDA020592
Product Classification
M
Marketing Category
C73594
G
Generic Name
Olanzapine
Product Specifications
Route of AdministrationORAL
Effective DateDecember 4, 2009
FDA Product Classification

INGREDIENTS (11)

Carnauba waxInactive
Code: R12CBM0EIZ
Classification: IACT
OlanzapineActive
Quantity: 20 mg in 1 1
Code: N7U69T4SZR
Classification: ACTIB
Hydroxypropyl celluloseInactive
Code: RFW2ET671P
Classification: IACT
LactoseInactive
Code: J2B2A4N98G
Classification: IACT
CrospovidoneInactive
Code: 68401960MK
Classification: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
Magnesium stearateInactive
Code: 70097M6I30
Classification: IACT
Cellulose, MicrocrystallineInactive
Code: OP1R32D61U
Classification: IACT
Titanium dioxideInactive
Code: 15FIX9V2JP
Classification: IACT
Ferric Oxide RedInactive
Code: 1K09F3G675
Classification: IACT
Polyethylene glycol 4000Inactive
Code: 4R4HFI6D95
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Zyprexa - FDA Drug Approval Details